Development of ROBINS-I was funded by a Methods Innovation Fund grant from Cochrane and Medical Research Council grant MR/M025209/1. Sterne and Higgins are members of the Medical Research Council Integrative Epidemiology Unit at the University of Bristol which is supported by the Medical Research Council and the University of Bristol (grant MC_UU_12013/9). This research was partly funded by NIH grant P01 CA134294. Sterne was supported by National Institute for Health Research Senior Investigator award NF-SI-0611-10168. Savović and Whiting were supported by National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care West (NIHR CLAHRC West). Reeves was supported by the National Institute for Health ...
Abstract Background The Cochrane Bias Methods Group r...
Objective The objective of this study was to evaluate the methodological conduct, reporting, and ris...
BACKGROUND: Systematic reviews of the effects of healthcare interventions frequently include non-ran...
Non-randomised studies of the effects of interventions are critical to many areas of healthcare eval...
Non-randomized studies of the effects of interventions are critical to many areas of health care eva...
Non-randomised studies of the effects of interventions are critical to many areas of healthcare eval...
Non-randomised studies of the effects of interventions are critical to many areas of healthcare eval...
Background: A new tool to assess Risk of Bias In Non-randomised Studies of Interventions (ROBINS-...
To provide guidance on how systematic review authors, guideline developers, and health technology as...
BackgroundSystematic reviews, which assess the risk of bias in included studies, are increasingly us...
The objective of this paper is to explain how to apply, interpret, and present the results of a new ...
Abstract Background Systematic reviews, which assess the risk of bias in included studies, are incre...
Assessment of risk of bias is regarded as an essential component of a systematic review on the effec...
The objective of this paper is to explain how to apply, interpret, and present the results of a new ...
Assessment of risk of bias is regarded as an essential component of a systematic review on the effec...
Abstract Background The Cochrane Bias Methods Group r...
Objective The objective of this study was to evaluate the methodological conduct, reporting, and ris...
BACKGROUND: Systematic reviews of the effects of healthcare interventions frequently include non-ran...
Non-randomised studies of the effects of interventions are critical to many areas of healthcare eval...
Non-randomized studies of the effects of interventions are critical to many areas of health care eva...
Non-randomised studies of the effects of interventions are critical to many areas of healthcare eval...
Non-randomised studies of the effects of interventions are critical to many areas of healthcare eval...
Background: A new tool to assess Risk of Bias In Non-randomised Studies of Interventions (ROBINS-...
To provide guidance on how systematic review authors, guideline developers, and health technology as...
BackgroundSystematic reviews, which assess the risk of bias in included studies, are increasingly us...
The objective of this paper is to explain how to apply, interpret, and present the results of a new ...
Abstract Background Systematic reviews, which assess the risk of bias in included studies, are incre...
Assessment of risk of bias is regarded as an essential component of a systematic review on the effec...
The objective of this paper is to explain how to apply, interpret, and present the results of a new ...
Assessment of risk of bias is regarded as an essential component of a systematic review on the effec...
Abstract Background The Cochrane Bias Methods Group r...
Objective The objective of this study was to evaluate the methodological conduct, reporting, and ris...
BACKGROUND: Systematic reviews of the effects of healthcare interventions frequently include non-ran...